GW Pharmaceuticals (GWPH) reported more positive phase 3 trial results for the cannabis -based drug it is developing to treat rare forms of epilepsy, …
GW Pharmaceuticals (GWPH) reported more positive phase 3 trial results for the cannabis -based drug it is developing to treat rare forms of epilepsy, …